Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas

Anticancer Research

Volumn 20, Issue 5 C, 2000, Pages 3775-3779

  Younes, M ^a   Pathak, M ^a   Finnie, D ^a   Sifers, R N ^a   Liu, Y ^a   Schwartz, M R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Amino acid transporter; ASCT1; Cancer; Esophagus; Glucose transporter; Glut 1; Glut1; Immunohistochemistry; Squamous cell carcinoma

Indexed keywords

AMINO ACID TRANSPORTER; CARRIER PROTEIN; GLUCOSE TRANSPORTER; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ADENOCARCINOMA; AMINO ACID METABOLISM; AMINO ACID TRANSPORT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; AMINO ACID TRANSPORT SYSTEMS; AMINO ACIDS; ANIMALS; ANTIBODIES; BIOLOGICAL TRANSPORT; CARCINOMA, HEPATOCELLULAR; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; ESOPHAGEAL NEOPLASMS; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MONOSACCHARIDE TRANSPORT PROTEINS; RABBITS; TUMOR CELLS, CULTURED;

EID: 0034529236     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Amino acid transport in tumor cells
2. Sugar and amino acid transport by cells in culture-differences between normal and malignant cells
3. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers
4. Human erythrocyte glucose transporter (Glut1) is immunohistochemically detected as a late event during malignant progression in Barrett's metaplasia
5. Cloning and expression of a human neutral amino acid transporter with structural similarity to the glutamate transporter gene family
6. Cloning and expression of a novel Na(+)-dependent neutral amino acid transporter structurally related to mammalian Na+/glutamate cotransporters
7. Expressed, human hippocampal ASCT1 amino acid transporter exhibits a pH-dependent change in substrate specificity
8. An amino acid transport system of unassigned function in the Ehrlich ascites tumor cell
9. Sodium-dependent amino acid transport in reconstituted membrane vesicles from Ehrlich ascites cell plasma membranes
10. Reconstitution of neutral amino acid transport system from Ehrlich ascites tumor cells
11. Surprising differences in substrate selectivity and other properties of systems A and ASC between rat hepatocytes and the hepatoma cell line HTC
12. Growth regulation and amino acid transport in epithelial cells: Influence of culture conditions and transformation on A, ASC, and L transport activities
13. Transport of potassium, amino acids, and glucose in cells transformed by Rous sarcoma virus
14. Amino acid supply and protein metabolism in Ehrlich ascites tumour cells. 1. Identification of limiting amino acids
15. Density-dependent regulation of amino acid transport in a Burkitt lymphoma cell line
16. Amino acid transport systems in the human hepatoma cell line Hep G2
17. Glutamine transport in isolated human hepatocytes and transformed liver cells
18. Characterization and growth factor stimulation of L-arginine transport in a human colon cancer cell line
19. Tumor cell invasion of basement membrane in vitro is regulated by amino acids
20. 'Facilitated' amino acid transport is upregulated in brain tumors
21. Substrate balances across colonic carcinomas in humans
22. 13C]leucine
23. Positron emission tomography: Current role for diagnosis and therapy monitoring in oncology
24. Diagnosis of spine metastases by FDG imaging using a gamma camera in the coincidence mode
25. 18F]-fluoro-2- deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease
26. Diagnosis and staging of pancreatic cancer by positron emission tomography
27. 18FDG-positron emission tomography in pancreatic cancer
28. Evaluation of FDG PET in patients with cervical cancer
29. 18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)1 whole body scans and elevated serum thyroglobulin levels
30. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography
31. 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer
32. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer
33. Tumor imaging with carbon-11 labeled alpha-aminoisobutyric acid (AIB) in a patient with advanced malignant melanoma
34. 123I] iodo-alpha-methyl tyrosine: Comparison with PET, 1241MT and first clinical results
35. Increased amino acid transport into brain tumors measured by PET of L- (2- 18F)fluorotyrosine
36. Re-evaluation of amino acid PET studies: Can the protein synthesis rates in brain and tumor tissues be measured in vivo?
37. Feasibility of fluorine-18-fluorophenylalanine for tumor imaging cpmpared with carbon-11-L-methionine
38. Carbon-11 labeled ethionine and propionine as tumor detecting agents
39. GLUT1 expression in human breast carcinoma: Correlation with known prognostic markers
40. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases
41. GLUT1 glucose transporter expression in colorectal carcinoma: A marker for poor prognosis
42. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival
43. Human neutral amino acid transporter ASCT1: Structure of the gene (SLC1 A4) and localization to chromosome 2p13-p15